NICE recommends new haemolytic anaemia treatment
The National Institute For Health and Care Excellence (NICE)'s decision…
The National Institute For Health and Care Excellence (NICE)'s decision follows a reduction in the price of Pfizer’s small molecule treatment for sickle cell disease.